Increased TNFSF13B can be contrasted with the expression of CD19, a marker of B cells, which was consistently suppressed relative to healthy controls among all three RA groups, as has been previously reported (Holden et al., 2011). The gene discussed is TNFSF13B; the disease is rheumatoid arthritis.